Commentary: Hormonal contraception and HIV acquisition - Current evidence and ongoing research needs

International Journal of Epidemiology

Volumn 36, Issue 1, 2007, Pages 175-177

  Morrison, Charles S ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

Depo provera; Heterosexual transmission; HIV acquisition; Hormonal contraception; Oral contraceptives; Research; Women

Indexed keywords

ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ENANTATE; ORAL CONTRACEPTIVE AGENT;

AGE DISTRIBUTION; CANCER SCREENING; DISEASE ASSOCIATION; DRUG USE; HERPES SIMPLEX; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MACACA; MEDICAL RESEARCH; METHODOLOGY; NONHUMAN; NOTE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEXUALLY TRANSMITTED DISEASE; SIMIAN IMMUNODEFICIENCY VIRUS; SOUTH AFRICA; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; VIRUS TRANSMISSION;

ADULT; AGE DISTRIBUTION; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; EPIDEMIOLOGIC RESEARCH DESIGN; FEMALE; HIV INFECTIONS; HUMANS; MIDDLE AGED; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES;

EID: 34447331311     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyl304     Document Type: Note

References (13)

1. Population Reference Bureau. Family Planning Worldwide 2002 Data Sheet. Washington, DC: Population Reference Bureau, 2002.
2. Myer L, Denny L, Wright T et al. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol 2007;36:166-74.
3. Department of Health of South Africa. South African Demographic and Health Survey 1998. Pretoria: South African Department of Health, Medical Research Council, Macro International, 2001.
4. Marx PA, Spira AI, Gettie A et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996;2 1084-89.
5. Smith SM, Meffora M, Sodora D et al. Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS 2004;18:1637-43.
6. Abel K, Rourke T, Lu D et al. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239. J Infect Dis 2004;190:1697-705.
7. Trunova N, Tsai L, Tung S et al. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected macaques. Virology 2006;352:169-77.
8. Smith SM, Baskin GB, Marx PA. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis 2000;182:708-15.
9. Morrison CS, Richardson BA, Mmiro F et al. Hormonal contraception and the risk of HIV Acquisition. AIDS 2007;21:85-95.
10. Wang CC, Reilly M, Kreiss JK. Risk of HIV infection in oral contraceptive pill users: A meta-analysis. J Acquir Immune Defic Syndr 1999;21:51-58.
11. Stephenson JM. Systematic review of hormonal contraception and risk of HIV transmission: When to resist meta-analysis. AIDS 1998;12 545-53.
12. Shisana O, Rehle T, Simbayi LC et al. South African National HIV Prevalence. HIV Incidence, Behavior and Communication Survey, 2005. Cape Town: HSRC Press, 2005.
13. Kleinschmidt I, Rees H, Delany S et al. Injectable Progestin Contraceptive Use and Risk of HIV Infection in a South African Family Planning Cohort. 12th Priorities in Reproductive Health & HIV Conference. Cape Town, South Africa, 21 October, 2005.